Tradestie Institutional Equity Comparison Engine
PRAX vs MLTX โ Head-to-Head Terminal
6-dimension institutional benchmarking across valuation, multi-year operating margins, normalized momentum, and dealer gamma corridors.
Pillar 1 Executive Scorecard & Category Winner Tally
PRAX Overall Edge
PRAX Captures Institutional Edge (3โ0 Pillars ยท 4โ2 Matrix Metrics)
Tradestie Institutional Equity Comparison Engine assigns the overall head-to-head edge to Praxis Precision Medicines, Inc. Common Stock (PRAX) driven by superior Growth & Margin, Momentum & Technical, Options & Structure. Fundamentally, PRAX trades at N/M Forward P/E with 0.0% operating margin (+1349.1% YoY revenue) versus MLTX at N/M Forward P/E and 0.0% operating margin (+0.0% YoY). In options structure, PRAX sits in CONSOLIDATION (4th %ile IV; Dealer Gamma Walls on Pro) against MLTX sits in BREAKDOWN (7th %ile IV; Dealer Gamma Walls on Pro).
Valuation Winner
Tie
PRAX N/M vs MLTX N/M Fwd P/E
Growth & Margin Winner
PRAX
Op Margin 0.0% vs 0.0% ยท YoY +1349.1% vs +0.0%
Momentum & Technical Winner
PRAX
1Y +73.6% vs -5.7% ยท 52W Pos 64% vs 17%
Options & Structure Winner
PRAX
CONSOLIDATION (4th %ile IV) vs BREAKDOWN (7th %ile IV)
PRAX
NASDAQ
Praxis Precision Medicines, Inc. Common Stock
Pharmaceutical Preparations
$309.08
-5.81% 1D
Market Cap
$9.1B
1M Return
+27.85%
1Y Return
+73.56%
Forward P/E
N/M
Unified AI Score
34.6 / 100
SELL
Tech 15.0
Fund 37.0
Flow 71.0
Mom 50.0
MLTX
NASDAQ
MoonLake Immunotherapeutics Class A Ordinary Shares
Pharmaceutical Preparations
$11.85
-5.2% 1D
Market Cap
$1.1B
1M Return
+24.08%
1Y Return
-5.65%
Forward P/E
N/M
Unified AI Score
38.3 / 100
SELL
Tech 32.0
Fund 44.0
Flow 75.0
Mom 50.0
Pillar 2 Normalized Relative Return Performance (% Indexed to 0%)
1Y Indexed Return:
PRAX +73.56%
MLTX -5.65%
Spread: +79.21 pp (PRAX Lead)
Pillar 3 Operating Profitability Benchmark (Trailing 12-Month)
PRAX TTM Op. Margin: 0.0%
MLTX TTM Op. Margin: 0.0%
Standardized multi-year USD domestic revenue schedules are unavailable for foreign-domiciled ADR filing schedules on PRAX vs MLTX. Trailing 12-month operating profitability (PRAX 0.0% vs MLTX 0.0%) and valuation multiples (PRAX N/M vs MLTX N/M Forward P/E) are benchmarked directly in Pillar 4 below.
Pillar 4 Head-to-Head Fundamental & Valuation Matrix
| Institutional Metric | PRAX | MLTX | Criterion | Row Winner |
|---|---|---|---|---|
| Market Capitalization Scale | $9.1B | $1.1B | Larger Scale | PRAX |
| Trailing P/E Ratio Valuation | N/M | N/M | Lower Multiple | Tie |
| Forward P/E Ratio Valuation | N/M | N/M | Lower Multiple | Tie |
| Revenue Growth (YoY) Growth | +1349.1% | +0.0% | Higher Growth | PRAX |
| Operating Margin (TTM) Profitability | 0.0% | 0.0% | Higher Margin | Tie |
| Net Profit Margin Profitability | 0.0% | 0.0% | Higher Margin | Tie |
| Return on Equity (ROE) Capital Efficiency | -44.8% | -81.5% | Higher ROE | PRAX |
| 52-Week Range Position Momentum | 64% ($160โ$393) | 17% ($9โ$23) | Stronger Trend | PRAX |
| Beta / 30D Volatility Risk Regime | 1.79ฮฒ ยท 93% Vol | 1.61ฮฒ ยท 90% Vol | Lower Realized Risk | MLTX |
| Unified Institutional Score Composite Signal | 34.6 / 100 (SELL) | 38.3 / 100 (SELL) | Higher Composite | MLTX |
Pillar 5 Options Structure, IV Regime & Dealer Gamma Corridor
Full PRAX vs MLTX Buy Guide
PRAX
CONSOLIDATION
67d in phase ยท OBV ACCUMULATION
Put Wall Floor
Pro Only
Call Wall Magnet
Pro Only
IV Percentile
4th %ile
IV Regime
Compressed (<25th %ile)
MLTX
BREAKDOWN
103d in phase ยท OBV ACCUMULATION
Put Wall Floor
Pro Only
Call Wall Magnet
Pro Only
IV Percentile
7th %ile
IV Regime
Compressed (<25th %ile)
Pillar 6 90-Day Technical & R&D Innovation Disclosures
Corporate R&D & Foundry Tracker
Neither PRAX nor MLTX registered frontier semiconductor/AI engineering publications in the trailing 90-day window; head-to-head edge is anchored on operating margin trajectory, valuation multiples, and options structure above.